Oryzon Genomics S.A. (BME:ORY)
Spain · Delayed Price · Currency is EUR 2.504
+0.004 (0.16%)
Oct 27, 2026, 10:32 AM CET
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of €205.23 million as of October 26, 2026. It is the 19,800th most valuable company in the world and the 110th biggest in Spain. Its market cap has decreased by 18.79% in one year.
Market Cap
205.23M
Enterprise Value
201.34M
Revenue
15.41M
Global Rank
Country Rank
#110 Spain
PE Ratio
n/a
ChartMarket Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 205.23M, an increase of 68.22%. That is a compound annual growth rate of 4.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 205.23M | -16.31% |
| Dec 31, 2025 | 245.23M | 170.69% |
| Dec 31, 2024 | 90.60M | -16.71% |
| Dec 29, 2023 | 108.78M | -18.27% |
| Dec 30, 2022 | 133.08M | -6.58% |
| Dec 30, 2021 | 142.46M | -32.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.06B |
| Laboratorios Farmaceuticos Rovi | 3.08B |
| Almirall | 2.26B |
| Faes Farma | 1.44B |
| Clínica Baviera | 862.58M |
| Prim, S.A. | 214.30M |
| Laboratorio Reig Jofre | 211.76M |
| Atrys Health | 198.12M |